ClinicalTrials.gov · 小核酸药物临床试验· Novartis Pharmaceuticals·· 2021-06-18AI 评分31
VICTORION-INITIATE：在ASCVD患者中评估"inclisiran优先"实施策略对比常规治疗的随机研究
A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)
AI 导读
一项随机研究评估"inclisiran优先"实施策略在动脉粥样硬化性心血管疾病（ASCVD）患者中的效果，即在最大耐受他汀治疗未能达标时立即加用inclisiran，并与常规治疗进行比较。研究针对接受最大耐受他汀治疗后LDL-C仍升高的ASCVD人群。
来源：ClinicalTrials.gov · 小核酸药物临床试验 · clinicaltrials.gov